Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Inverse agonist
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
{{Short description|Agent in biochemistry}} {{distinguish|Antagonist (disambiguation){{!}}Antagonist|Protagonist (disambiguation){{!}}Protagonist}} [[Image:Inverse agonist 3.svg|thumb|400 px|Dose response curves of a full agonist, partial agonist, neutral antagonist, and inverse agonist]] In [[pharmacology]], an '''inverse agonist''' is a [[drug]] that binds to the same [[receptor (biochemistry)|receptor]] as an [[agonist]] but induces a pharmacological response opposite to that of the agonist. A [[receptor antagonist|neutral antagonist]] has no activity in the absence of an agonist or inverse agonist but can block the activity of either;<ref>{{cite journal | vauthors = Kenakin T | title = Principles: receptor theory in pharmacology | journal = Trends in Pharmacological Sciences | volume = 25 | issue = 4 | pages = 186β92 | date = April 2004 | pmid = 15063082 | doi = 10.1016/j.tips.2004.02.012 }}</ref> they are in fact sometimes called ''blockers'' (examples include [[alpha blocker]]s, [[beta blocker]]s, and [[calcium channel blocker]]s). Inverse agonists have opposite actions to those of agonists but the effects of both of these can be blocked by antagonists.<ref name="pmid27955830">{{cite journal | vauthors = Nutt D, Stahl S, Blier P, Drago F, Zohar J, Wilson S |author-link1=David Nutt |title = Inverse agonists - What do they mean for psychiatry? | journal = European Neuropsychopharmacology | volume = 27 | issue = 1 | pages = 87β90 | date = January 2017 | pmid = 27955830 | doi = 10.1016/j.euroneuro.2016.11.013 | hdl = 10044/1/43624 |s2cid=25113284 | hdl-access = free }}</ref> A prerequisite for an inverse agonist response is that the receptor must have a [[receptor (biochemistry)#Constitutive activity|constitutive]] (also known as [[intrinsic activity|intrinsic]] or basal) level of activity in the absence of any [[ligand (biochemistry)|ligand]].<ref>{{Cite journal|last1=Berg|first1=Kelly A|last2=Clarke|first2=William P|date=2018-08-06|title=Making Sense of Pharmacology: Inverse Agonism and Functional Selectivity|journal=International Journal of Neuropsychopharmacology|volume=21|issue=10|pages=962β977|doi=10.1093/ijnp/pyy071|issn=1461-1457|pmc=6165953|pmid=30085126}}</ref> An agonist increases the activity of a receptor above its basal level, whereas an inverse agonist decreases the activity below the basal level. The [[efficacy]] of a full agonist is by definition 100%, a neutral antagonist has 0% efficacy, and an inverse agonist has < 0% (i.e., negative) efficacy.
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)